Encompass Health Corp 8-K

What Happened Encompass Health Corporation filed an 8-K on May 11, 2026 reporting the results of its Annual Meeting held May 7, 2026. Stockholders elected all 10 board nominees (Greg D. Carmichael; Edward M. Christie III; Cain A. Hayes; Joan E. Herman; Leslye G. Katz; Kevin J. O’Connor; Christopher R. Reidy; Nancy M. Schlichting; Mark J. Tarr; Terrance Williams), ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm, and approved the compensation of the company’s named executive officers (say-on-pay).

Key Details

• Record and participation: 99,565,304 shares outstanding as of the record date; proxies represented 92.5% of combined voting power at the meeting.
• Directors: All 10 nominees were elected; individual "For" votes ranged (per filed results) from about 83.86M to 85.90M.
• Auditor ratification: PricewaterhouseCoopers LLP was ratified — 88,444,873 votes for; 3,608,490 against; 68,452 abstained.
• Say-on-pay: Compensation for named executive officers was approved — 83,410,829 votes for; 3,006,776 against; 102,636 abstained. Proposals 1 and 3 recorded 5,601,574 broker non-votes; Proposal 2 had no broker non-votes.

Why It Matters This filing confirms board continuity (all incumbent/nominee directors elected), continued engagement with PwC as auditor, and shareholder approval of executive compensation—important governance signals for investors. The presence of broker non-votes on director and say-on-pay items indicates some institutional-held shares were not voted on those matters. The filing does not report financial results or operational changes.